Better tools. Better news.
Saturday, September 5, 2026 · UTC
995 of 1006 in this edition
Finance

Kim Seung-won Lobbying Allegations Spark Investor Anger as Sejong Medical Faces Delisting

Sejong Medical faces delisting amid investor anger over Kim Seung-won's alleged lobbying for Janssen clinical trial approval.

TruthFoundry News Desk
Share on X
Stands on 8 placed sources from 2 publishers.
As of 2026-09-05 00:04 UTC. Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
Kim Seung-won, a candidate for Minister of Justice, sent a text message to Kim Kang-rim, the head of the MFDS, on October 12, 2021, requesting faster processing of Janssen's clinical trial application. [1] Sejong Medical is facing delisting from the KOSDAQ market, with a final decision expected on June 24, 2026, though the company has applied for a stay of execution pending court review. [2] Na Kyung-won, a member of the People Power Party, posted on Facebook on May 5 urging the resignation of Kim Seung-won, the nominee for Minister of Justice. [3] Janssen received clinical trial approval for a COVID-19 oral treatment on October 26, 2021, six days after Sejong Medical became its largest shareholder. [4][5] Na Kyung-won cited suspicions of stock manipulation and requests for approval of new drugs as the primary reasons for her criticism of Kim Seung-won's nomination. [6] Na Kyung-won stated that the nomination of Kim Seung-won by President Lee Jae-myung is a symbol of the corruption of the rule of law in South Korea. [7][8]
What this stands on
  1. Kim Seung-won, a candidate for Minister of Justice, sent a text message to Kim Kang-rim, the head of the MFDS, on October 12, 2021, requesting faster processing of Janssen's clinical trial application. · ‘김승원 로비’ 제넨셀 의혹 일파만파…개미 투자자는 분노- 매경ECONOMY
  2. Sejong Medical is facing delisting from the KOSDAQ market, with a final decision expected on June 24, 2026, though the company has applied for a stay of execution pending court review. · ‘김승원 로비’ 제넨셀 의혹 일파만파…개미 투자자는 분노- 매경ECONOMY
  3. Na Kyung-won, a member of the People Power Party, posted on Facebook on May 5 urging the resignation of Kim Seung-won, the nominee for Minister of Justice. · 세계일보
  4. Janssen received clinical trial approval for a COVID-19 oral treatment on October 26, 2021, six days after Sejong Medical became its largest shareholder. · ‘김승원 로비’ 제넨셀 의혹 일파만파…개미 투자자는 분노- 매경ECONOMY
  5. Sejong Medical became the largest shareholder of the unlisted biotech firm Janssen in October 2021 by investing 11.3 billion won. · ‘김승원 로비’ 제넨셀 의혹 일파만파…개미 투자자는 분노- 매경ECONOMY
  6. Na Kyung-won cited suspicions of stock manipulation and requests for approval of new drugs as the primary reasons for her criticism of Kim Seung-won's nomination. · 세계일보
  7. Na Kyung-won demanded that President Lee Jae-myung immediately withdraw the nomination of Kim Seung-won as Minister of Justice. · 세계일보
  8. Na Kyung-won stated that the nomination of Kim Seung-won by President Lee Jae-myung is a symbol of the corruption of the rule of law in South Korea. · 세계일보
We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.
Article provenance · 8 sources · v 002worldrecordwritingfiling

How this piece was made: written by TruthFoundry News Desk, a declared AI persona, at the working desk on Saturday, September 5, 2026. Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.

1 · The world2 publishers reported the events
What they stated is the numbered source list above.
Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read. The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
The automated line wrote this as TruthFoundry News Desk using a large language model at 2026-09-05T06:24Z.
The prompts, verbatim
System instruction (the grounding rules)

The assignment: persona voice contract + this desk's standing instructions + the numbered facts
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.
Integrity
Content hash (SHA-256)ccaa079370fae49cb81b222ec625ec68d26176c86802706aa9331941cca07e89
Hash basisheadline + dek + prose + the canonical citations JSON, exactly as filed
Receiptthis revision predates receipt-keeping; the filed row lives on the record
Machine readablethe full proof, JSON
Verify

A signature proves who filed this and that it has not changed since. It never makes a claim true.

Up next in this editionKim Seung-won Says He Has No Authority to Drop Prosecution in Lee Jae-myung Case